Last updated 2026-07-27
TL;DR
Topical dapsone (Aczone 5%/7.5%) requires a prescription but no G6PD test in most cases; the FDA-approved label doesn't mandate one. Oral dapsone, used for dermatitis herpetiformis and other conditions, requires G6PD-deficiency screening before starting, because it can trigger hemolysis. The two drugs carry very different prescribing bars. Don't let anyone conflate them.
Do you need a prescription for dapsone at all?
Yes, both forms. There's no over-the-counter dapsone in the United States, topical or oral. Aczone (topical dapsone gel, 5% and 7.5%) is FDA-approved and prescription-only [1]. Oral dapsone tablets are prescription-only as well, and in practice almost always come from a dermatologist, infectious disease specialist, or a doctor treating a specific diagnosed condition like dermatitis herpetiformis or leprosy (Hansen's disease) [2]. The confusion online usually isn't about whether you need a prescription. It's about what has to happen before you get one. That's where topical and oral dapsone split hard, and it's the split this whole article is built around. If you're comparing the two forms for acne specifically: only topical dapsone is approved for acne. Oral dapsone is not an acne drug, and no reputable dermatologist prescribes it for acne given the monitoring burden and risk profile relative to a topical gel that works the skin surface only.
What does it take to get topical dapsone (Aczone) prescribed?
A visit (in person or telehealth) where a clinician looks at your skin, confirms acne (not rosacea or another look-alike condition), and writes the script. That's it in the overwhelming majority of cases. The FDA label for Aczone doesn't require G6PD testing before use. Topical dapsone is absorbed at low systemic levels: in the trials supporting Aczone 7.5% gel's approval, plasma dapsone concentrations were far below what's seen with oral dosing, and clinically meaningful hemolysis wasn't a signal in the approved labeling's warnings the way it is for the oral drug [1]. The Aczone prescribing information does note that G6PD deficient patients in clinical studies showed lab changes consistent with hemolysis (small drops in hemoglobin, upticks in reticulocytes) but these were not accompanied by clinical symptoms in most cases, and the label does not mandate universal G6PD screening before prescribing [1]. What you should still expect at a legitimate visit: a question about skin irritation history, whether you're pregnant or breastfeeding, and a note that combining benzoyl peroxide with Aczone can cause temporary yellow/orange skin discoloration (a real, well-documented cosmetic interaction, not a safety issue) [1]. For exact strengths and how much to apply, see Dapsone Rx dosage and the Dapsone Rx dosage calculator.
What does it take to get oral dapsone prescribed?
A lot more. Oral dapsone prescribing should include G6PD enzyme testing before the first dose, a baseline CBC, and ongoing monitoring, because the drug carries real, well-documented risks: hemolytic anemia, methemoglobinemia, agranulocytosis, and a rare but severe reaction called dapsone hypersensitivity syndrome [3] [4]. G6PD deficiency is a genetic condition, more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, where red blood cells lack enough of an enzyme that protects them from oxidative stress [5]. Dapsone is an oxidant drug. In someone with G6PD deficiency, oral dapsone can trigger acute, sometimes severe hemolysis, meaning red blood cells break down faster than the body replaces them. The dapsone oral tablet label states plainly that patients should be tested for G6PD deficiency prior to starting therapy, and that hemolysis and hemolytic anemia occur in a dose related manner with the drug, with more pronounced effects in G6PD deficient patients [3]. This is not a suggestion buried in fine print. It's built into how dermatologists and infectious disease doctors are trained to start the drug. Beyond the G6PD test, expect: baseline CBC with differential, repeat CBC checks (commonly weekly for the first month, then periodically), and clinician counseling on symptoms of methemoglobinemia (bluish skin/lips, shortness of breath, fatigue) and dapsone hypersensitivity syndrome (fever, rash, swollen lymph nodes, usually 2 to 6 weeks after starting) [4].
What is G6PD deficiency and why does it matter for dapsone?
G6PD (glucose-6-phosphate dehydrogenase) is an enzyme every red blood cell needs to handle oxidative stress. People with G6PD deficiency, an inherited X-linked condition, have red cells that are more fragile under oxidative drugs, certain foods (fava beans), and infections [5]. CDC resources describe G6PD deficiency as one of the most common enzyme deficiencies worldwide, with higher prevalence in populations from historically malaria-endemic regions (Africa, the Mediterranean, Middle East, Southeast Asia), because the trait offers some resistance to malaria [5]. Oral dapsone is one of the classic oxidant drugs that can cause acute hemolysis in G6PD deficient patients. This is why the G6PD test is a gate, not a formality, before starting oral therapy. A simple blood test (checking enzyme activity, sometimes with a quantitative assay) done once, before the first dose, tells your prescriber whether oral dapsone is even an option. For topical dapsone, the systemic exposure is low enough that the FDA label doesn't require this same testing as a precondition, though your prescriber may still ask about known G6PD status if you have a family history or ethnic background associated with higher prevalence [1] [5].
Does a telehealth visit meet the bar for prescribing dapsone?
For topical dapsone (Aczone), yes, generally. A photo-based or video dermatology telehealth visit is a normal, medically appropriate way to get a topical acne prescription, and this is the model most legitimate online dermatology services use, including provider-reviewed platforms like Dapsone Rx that route you to a licensed prescriber before any fulfillment happens. For oral dapsone, telehealth alone is a red flag if the visit doesn't include or arrange G6PD testing. Any legitimate oral dapsone prescriber, telehealth or in-person, should be ordering that lab test through a real lab (Quest, LabCorp, or a local draw site) before or immediately after the first prescription, not skipping it. If a website offers oral dapsone with zero mention of G6PD testing, that's not a shortcut, it's a missed safety step, and you should treat it as a reason to walk away. Dapsone Rx's role, worth being explicit about: the brand doesn't compound or manufacture dapsone itself. It connects patients to provider review and routes prescriptions to a licensed fulfilling pharmacy partner. The clinical decision, including whether G6PD testing is needed for your situation, sits with the prescribing clinician, not the platform.
What lab tests are actually required before starting dapsone?
| Prescription needed | Yes [1] | Yes [2] | |
|---|---|---|---|
| G6PD test required by label | Not mandated [1] | Yes, prior to initiation [3] | |
| Baseline CBC | Not routine | Standard practice [4] | |
| Ongoing blood monitoring | Not routine | Yes, periodic CBC [4] | |
| Approved use | Acne vulgaris [1] | Dermatitis herpetiformis, leprosy, other conditions [2] | |
| Common route to get it | Telehealth or in-person derm visit | Dermatologist or specialist, in-person more common | A baseline CBC (complete blood count) for oral dapsone gives your prescriber a starting point for hemoglobin, white blood cell count, and reticulocyte count, so they can catch early hemolysis or agranulocytosis on follow-up labs rather than after you're symptomatic [4]. Weekly CBCs for the first month, then monthly for several months, then periodically, is a common monitoring cadence described in dermatology literature, though exact schedules vary by prescriber and indication [4]. |
Here's the split in one table, because this is the fact people actually need before they book an appointment. | Requirement | Topical dapsone (Aczone) | Oral dapsone |
What are the real risks of oral dapsone that justify the screening?
Four risks show up consistently in the prescribing information and clinical literature: hemolytic anemia, methemoglobinemia, agranulocytosis, and dapsone hypersensitivity syndrome [3] [4]. Hemolytic anemia is dose-related and happens to some degree in nearly everyone on oral dapsone, G6PD-normal or not, but it becomes dangerous fast in G6PD deficient patients [3]. Methemoglobinemia is a condition where hemoglobin is chemically altered so it can't carry oxygen properly, causing cyanosis (bluish skin), fatigue, and shortness of breath; it's a known dose-related effect of dapsone in essentially all patients, more than G6PD deficient ones [3] [4]. Agranulocytosis, a dangerous drop in a specific white blood cell type, is rarer but severe, and dermatology references note it can appear even after weeks of uneventful therapy, which is exactly why the CBC checks continue past the first month [4]. Dapsone hypersensitivity syndrome is a delayed, severe reaction (fever, rash, organ involvement) that typically shows up 2 to 6 weeks after starting the drug and has a reported mortality in the range of 9.9% in some published series, which is why prescribers watch closely in that window rather than treating the first month as a formality [4]. None of this is a reason to panic if your dermatologist has prescribed oral dapsone for a real diagnosis like dermatitis herpetiformis. It's a reason the screening and monitoring exist, and a reason to never accept oral dapsone from any source that skips them.
Can you get dapsone prescribed for acne specifically?
Yes, topical. Aczone 7.5% gel is FDA-approved for acne vulgaris in patients 12 years and older, and Aczone 5% gel carries a similar approval history for acne in patients 12 and older [1]. This is the form nearly everyone searching "dapsone for acne" actually means. Clinical trial data submitted for Aczone 7.5% gel approval showed statistically significant reduction in inflammatory and noninflammatory acne lesions compared to vehicle gel over 12 weeks, per FDA review documentation [1]. It's a once-daily topical, not a systemic antibiotic course, and the prescribing bar reflects that: a derm visit, a look at your skin, a script. Oral dapsone is not prescribed for acne in standard dermatology practice. It's reserved for conditions where its systemic anti-inflammatory and antimicrobial effect is needed and where the monitoring burden is justified, chiefly dermatitis herpetiformis (an itchy, blistering skin condition linked to celiac disease) and, globally, leprosy [2]. If a website is offering you oral dapsone specifically framed as an acne treatment, that's a mismatch with how the drug is actually used in dermatology, and it should raise a question about who's writing that prescription and why.
How much does dapsone cost with and without insurance?
Generic topical dapsone gel has brought prices down substantially since Aczone's generic competition arrived; GoodRx-tracked cash prices for generic dapsone gel 5% or 7.5% commonly run in the range of $40 to $150 for a 30-60 gram tube depending on pharmacy and location, though this fluctuates and isn't something we can pin to one fixed number reliably given pharmacy-to-pharmacy variation. Brand-name Aczone without insurance or a manufacturer coupon can run considerably higher. Oral dapsone tablets (generic) are typically inexpensive per tablet, but the real cost driver isn't the drug, it's the monitoring: G6PD testing, baseline CBC, and repeat CBCs add lab fees and office visit costs on top of the prescription itself. Insurance coverage for both forms varies by plan and diagnosis; oral dapsone for an FDA-approved indication like dermatitis herpetiformis is more reliably covered than off-label uses. If cost is the deciding factor between forms, remember you're not actually choosing between two options for the same problem. Topical treats acne on the skin surface. Oral dapsone treats different, specific systemic conditions and was never a cheaper substitute for the topical route.
What should you ask your prescriber before starting either form?
For topical dapsone: ask about the benzoyl peroxide discoloration interaction, how long before you see results (commonly 12 weeks in trial data) [1], and whether 5% or 7.5% fits your skin. See Dapsone Rx dosage for strength comparisons. For oral dapsone: ask directly, "Have I been tested for G6PD deficiency, and what were the results?" Ask what your monitoring schedule looks like for the first three months. Ask what symptoms mean you should stop the drug and call immediately (blue-tinged skin, unusual fatigue, fever with rash, sore throat that won't quit, since that last one can flag a white cell problem). If you're already on oral dapsone and managing dosing logistics, related guidance covers Dapsone Rx dosage, how to reconstitute Dapsone Rx, Dapsone Rx how to inject, Dapsone Rx injection sites, and Dapsone Rx cycle length. None of those replace the G6PD conversation with your prescriber; they're logistics, not a substitute for screening.
Frequently asked questions
Do you need a G6PD test for topical dapsone gel?
Not routinely. The FDA label for Aczone (topical dapsone) doesn't mandate G6PD testing before use, because systemic absorption through the skin is low. Some prescribers may still ask about known G6PD status if you have relevant family history, but it's not a required precondition the way it is for oral dapsone.
Is dapsone available over the counter?
No. Both topical dapsone (Aczone 5%/7.5%) and oral dapsone tablets are prescription-only in the United States. There is no OTC version of either form. Any product claiming to be OTC dapsone should be treated as suspect.
Why does oral dapsone require G6PD testing but topical doesn't?
Oral dapsone reaches meaningful blood levels and can trigger dose-related hemolysis, which becomes dangerous in people with G6PD enzyme deficiency. Topical dapsone gel has much lower systemic absorption, so the FDA-approved label for Aczone doesn't require the same pre-treatment G6PD screening that the oral tablet label explicitly calls for.
Can dermatologists prescribe oral dapsone for acne?
It happens rarely and isn't standard practice. Oral dapsone isn't FDA-approved for acne; it's approved for conditions like dermatitis herpetiformis and leprosy. Given the G6PD screening, CBC monitoring, and hemolysis/agranulocytosis risks involved, most dermatologists reserve oral dapsone for its approved indications and use topical dapsone for acne instead.
What blood tests are needed before starting oral dapsone?
A G6PD enzyme test before your first dose, plus a baseline complete blood count (CBC). Prescribers then typically repeat CBCs weekly for the first month and periodically after, watching for hemolytic anemia, methemoglobinemia, or agranulocytosis, which are documented risks of oral dapsone therapy.
What is dapsone hypersensitivity syndrome?
A rare, severe delayed reaction to oral dapsone, usually appearing 2 to 6 weeks after starting the drug, with fever, rash, and swollen lymph nodes, sometimes progressing to organ involvement. Published case series report mortality rates around 9.9% in some cohorts, which is why prescribers monitor closely during this window.
How long does it take for topical dapsone to work on acne?
Clinical trial data supporting Aczone's FDA approval measured lesion reduction over a 12-week period, and most dermatologists tell patients to expect gradual improvement over roughly that timeframe rather than a fast fix. It's a daily topical, not a quick-acting spot treatment.
Can you get dapsone prescribed through telehealth?
For topical dapsone, yes; a telehealth visit with a licensed prescriber is a normal, medically accepted route. For oral dapsone, telehealth is only appropriate if the visit includes or arranges G6PD testing and follow-up labs. If a telehealth service skips G6PD screening for oral dapsone, that's a legitimate red flag.
What ethnic groups have higher rates of G6PD deficiency?
G6PD deficiency is more common in people with ancestry from Africa, the Mediterranean, the Middle East, and Southeast Asia, historically linked to regions where the trait offered some resistance to malaria. It's one of the most common enzyme deficiencies known worldwide, per CDC background on newborn screening for the condition.
Does benzoyl peroxide interact with topical dapsone?
Yes, but it's cosmetic, not dangerous. Combining benzoyl peroxide with Aczone gel can cause temporary yellow or orange skin discoloration. It's a well-documented interaction in the Aczone prescribing information, not a safety warning, but worth knowing before you layer the two products.
Is oral dapsone used for anything besides acne and dermatitis herpetiformis?
Yes. Oral dapsone's primary FDA-recognized uses are dermatitis herpetiformis and leprosy (Hansen's disease). It's not approved for acne at all. Off-label uses exist in some specialist settings, but each still requires the same G6PD screening and blood monitoring given the drug's hemolysis and agranulocytosis risks.
What symptoms mean you should stop oral dapsone and call your doctor?
Bluish or gray-tinged skin and lips, unusual shortness of breath or fatigue (possible methemoglobinemia), fever with rash appearing weeks after starting (possible dapsone hypersensitivity syndrome), and sore throat or signs of infection (possible agranulocytosis). Any of these warrants an immediate call, not a wait-and-see approach.
Sources
- FDA, Aczone (dapsone) gel 7.5% label/approval: Aczone 7.5% gel is FDA-approved for acne vulgaris in patients 12 and older, prescription-only
- FDA, dapsone tablets prescribing information, DailyMed record: Oral dapsone tablets are prescription-only and approved for dermatitis herpetiformis and leprosy
- DailyMed, Dapsone tablets, USP label, Warnings section: Oral dapsone label states patients should be tested for G6PD deficiency prior to initiation; hemolysis is dose-related
- StatPearls (NCBI Bookshelf), Dapsone: Monitoring schedule (weekly then periodic CBC), risks of agranulocytosis and dapsone hypersensitivity syndrome, mortality estimate
- CDC, Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD deficiency is an inherited enzyme deficiency more common in certain ancestral populations, global prevalence context